|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||13.77 - 13.98|
|52-week range||5.65 - 14.82|
|Beta (5Y monthly)||1.15|
|PE ratio (TTM)||40.96|
|Forward dividend & yield||0.07 (0.51%)|
|Ex-dividend date||07 Apr 2022|
|1y target est||13.00|
Swiss dental implants maker Straumann maintained its moderate 2022 outlook on Tuesday despite strong first-half sales driven by high demand, sending its shares tumbling as much as 10% in afternoon trading. "Straumann is often conservative, but we believe there had been some hope from bulls for an upgrade" to the year's forecast, J.P.Morgan said in a note, adding the outlook implied a sharp slowdown in the latter half of the year. The company, which specialises in tooth replacement and orthodontic solutions, sees full-year organic sales growth in the low-double-digit percentage rage, against 21% growth in the first six months.
GENEVA & BASEL, Switzerland, June 08, 2022--Please replace the release with the following corrected version due to multiple revisions.